It is good to see that they are obviously still very active in other areas other than the oncology. As long as they keep showing improved results for existing drug delivery hopefully at some point someone gets interested enough to put up some cash.
I wonder how far it still is to human trials of these sort of therapies. On the one hand i assume cpp is still very new, yet on the other hand at least in usa it seems fda can grant orphan drug status and speed the time to market for something that shows effectiveness on previously untreatable diseases.
Ann: Cell-Penetrating Phylomers Improve Delivery of Drugs-PYC.AX, page-3
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.27 |
Change
0.005(0.40%) |
Mkt cap ! $740.7M | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.29 | $1.27 | $406.0K | 319.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 13987 | $1.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.29 | 1380 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |